/ALSAF.PA
ALSAF.PA Stock - Safe Orthopaedics S.A.
Healthcare|Medical - Instruments & SuppliesPAR
$1.46-0.64%
$0.01 (-0.64%) • Dec 23
65
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.41
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.61
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ALSAF.PA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.45 – $1.48
TARGET (TP)$1.68
STOP LOSS$1.34
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.16
52W High$2.60
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $5.81M | $5.86M | $4.55M | $3.66M | $4.70M |
| Gross Profit | $4.32M | $-4,358,000 | $-5,740,000 | $-5,052,000 | $-3,827,000 |
| Gross Margin | 74.4% | -74.4% | -126.0% | -138.1% | -81.4% |
| Operating Income | $-7,978,000 | $-5,962,000 | $-7,582,000 | $-6,668,000 | $-7,457,000 |
| Net Income | $-205,444,000 | $-6,965,000 | $-6,709,000 | $-8,306,000 | $-7,970,000 |
| Net Margin | -3536.0% | -118.8% | -147.3% | -227.1% | -169.6% |
| EPS | $-2706764.00 | $-96154.00 | $-92620.00 | $-227853436.00 | $-32632261665.00 |
Company Overview
Safe Orthopaedics SA, a medical technology company, develops and markets sterile implants and single-use instruments for the treatment of spinal fracture pathologies in France and internationally. The company offers SteriSpine PS, an all-round kit for the treatment of spinal fractures and degenerative pathologies; and SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems. It also provides SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut. The company was founded in 2010 and is headquartered in Éragny-sur-Oise, France.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ALSAF.PABeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-1585389.75
Q3 2024
EPS Surprise History
Q3 20
No data
Q4 20
No data
Q4 21
No data
Q2 22
No data
Q4 22
No data
Q2 23
No data
Q2 24
No data
Q3 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Dec 1, 2025 | — | — | — | — |
Q1 2025 | Feb 12, 2025 | — | — | — | — |
Q3 2024 | Jul 29, 2024 | — | $-1585389.75 | — | — |
Q2 2024 | Apr 30, 2024 | — | $-2348259.93 | — | — |
Q4 2023 | Oct 17, 2023 | — | — | — | — |
Q2 2023 | Apr 13, 2023 | — | $-25062.92 | — | — |
Q4 2022 | Oct 6, 2022 | — | $-31909.42 | — | — |
Q2 2022 | Apr 21, 2022 | — | $-20392.25 | — | — |
Q4 2021 | Oct 7, 2021 | — | $-34486.06 | — | — |
Q4 2020 | Dec 29, 2020 | — | $-130742773.64 | — | — |
Q3 2020 | Jul 30, 2020 | — | $-97110662.76 | — | — |
Q2 2020 | May 6, 2020 | — | $-15800238113.58 | — | — |
Q3 2019 | Sep 28, 2019 | — | $-16832023551.42 | — | — |
Q2 2019 | Apr 26, 2019 | — | $-158091203343.52 | — | — |
Q4 2018 | Oct 8, 2018 | — | $-138649566686.38 | — | — |
Q2 2018 | Apr 27, 2018 | — | $-170370131758.55 | — | — |
Q4 2017 | Oct 9, 2017 | — | $-166021344611.56 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-278993089358.41 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-405942929283.15 | — | — |
Q4 2015 | Dec 31, 2015 | — | $-437879995.93 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ALSAF.PA
What is ALSAF.PA's current stock price?
Safe Orthopaedics S.A. (ALSAF.PA) is currently trading at $1.46 per share. The stock has moved -0.64% today.
What is the analyst price target for ALSAF.PA?
No analyst price targets are currently available for this stock.
What sector is Safe Orthopaedics S.A. in?
Safe Orthopaedics S.A. operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the PAR exchange.
What is ALSAF.PA's market cap?
Safe Orthopaedics S.A. has a market capitalization of $0.00 billion, making it a small-cap company.
Does ALSAF.PA pay dividends?
No, Safe Orthopaedics S.A. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALALO.PA
Acheter-Louer.Fr S.A.
$0.09
Mkt Cap: $0.0B
ALBPS.PA
Biophytis S.A.
$0.07
Mkt Cap: $0.0B
ALNEV.PA
Neovacs S.A.
$0.01
Mkt Cap: $0.0B
ALSGD.PA
SpineGuard S.A.
$0.10
Mkt Cap: $0.0B
ALSPW.PA
Spineway S.A.
$0.15
Mkt Cap: $0.0B
Explore stocks similar to ALSAF.PA for comparison